Ventures Llc Syntone serves as Executive at Outlook Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ventures Llc Syntone has executed 3 insider transactions totaling $4.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 15, 2024 involved purchasing 714,286 shares valued at $0.
Ventures Llc Syntone currently holds 1,705,438 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Llc Syntone has been a net buyer of OTLK stock. They have purchased $4.0M and sold $0 worth of shares.
Ventures Llc Syntone's most recent insider trade was on Apr 15, 2024, when they purchased 714,286 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.00 |
| Discretionary |
| Jul 15, 2020 | OTLK | $1.0M | Purchase | 823,045 | $1.22 | Discretionary |